B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07830238	SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia	not yet recruiting	Early Phase 1	28	Shanghai Simnova Biotechnology Co.,Ltd.INDUSTRY	1	Sep 21, 2026	clinicaltrials
NCT07277504	Autologous Bedside CD19 CAR T-cell Therapy for B-ALL	not yet recruiting	Early Phase 1	50	The General Hospital of Western Theater CommandOTHER	1	Dec 11, 2025	clinicaltrials